Published in Medical Letter on the CDC and FDA, September 21st, 2008
"Two hundred and forty patients who took warfarin after surgery were divided into two groups: Group I (n=114) had rabeprazole (10 mg/day) and Group II (n=126)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.